SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-18-079236
Filing Date
2018-03-12
Accepted
2018-03-12 16:10:32
Documents
2
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d547895d10ka.htm 10-K/A 66133
2 EX-32.1 d547895dex321.htm EX-32.1 3612
  Complete submission text file 0001193125-18-079236.txt   70761
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36070 | Film No.: 18683481
SIC: 2834 Pharmaceutical Preparations